CSS LLC’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

CSS LLC’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-130,700	Closed	-$6.27M	–	818
2020 Q1	$6.27M	Buy	+130,700	New	+$6.08M	0.5%	42

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

CSS LLC's RARX Position: Q2 2020 in Review

CSS LLC sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 88,973 shares — an estimated $4.27M sold.

CSS LLC first reported a position in RARX in Q1 2020 and held it in 1 quarter. The position peaked at $4.27M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

CSS LLC reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
CSS LLC sold 88,973 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $4.27M.
CSS LLC first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
CSS LLC's Ra Pharmaceuticals, Inc. Common Stock position peaked at $4.27M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on CSS LLC's 13F filing for Q2 2020, filed 14 Aug 2020.